🇺🇸 Xiapex in United States

59 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Pain In Extremity — 10 reports (16.95%)
  2. Contusion — 8 reports (13.56%)
  3. Laceration — 7 reports (11.86%)
  4. Fracture Of Penis — 6 reports (10.17%)
  5. Peripheral Swelling — 6 reports (10.17%)
  6. Blood Blister — 5 reports (8.47%)
  7. Pain — 5 reports (8.47%)
  8. Complex Regional Pain Syndrome — 4 reports (6.78%)
  9. Dupuytren^S Contracture — 4 reports (6.78%)
  10. Ecchymosis — 4 reports (6.78%)

Source database →

Xiapex in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Xiapex approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Xiapex in United States?

University Hospital, Akershus is the originator. The local marketing authorisation holder may differ — check the official source linked above.